429 related articles for article (PubMed ID: 23645227)
1. Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4.
; Chew EY; SanGiovanni JP; Ferris FL; Wong WT; Agron E; Clemons TE; Sperduto R; Danis R; Chandra SR; Blodi BA; Domalpally A; Elman MJ; Antoszyk AN; Ruby AJ; Orth D; Bressler SB; Fish GE; Hubbard GB; Klein ML; Friberg TR; Rosenfeld PJ; Toth CA; Bernstein P
JAMA Ophthalmol; 2013 Jul; 131(7):843-50. PubMed ID: 23645227
[TBL] [Abstract][Full Text] [Related]
2. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.
; Chew EY; Clemons TE; Sangiovanni JP; Danis RP; Ferris FL; Elman MJ; Antoszyk AN; Ruby AJ; Orth D; Bressler SB; Fish GE; Hubbard GB; Klein ML; Chandra SR; Blodi BA; Domalpally A; Friberg T; Wong WT; Rosenfeld PJ; Agrón E; Toth CA; Bernstein PS; Sperduto RD
JAMA Ophthalmol; 2014 Feb; 132(2):142-9. PubMed ID: 24310343
[TBL] [Abstract][Full Text] [Related]
3. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
Age-Related Eye Disease Study 2 Research Group
JAMA; 2013 May; 309(19):2005-15. PubMed ID: 23644932
[TBL] [Abstract][Full Text] [Related]
4. Association of Mortality with Ocular Diseases and Visual Impairment in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13.
; Papudesu C; Clemons TE; Agrón E; Chew EY
Ophthalmology; 2018 Apr; 125(4):512-521. PubMed ID: 29153456
[TBL] [Abstract][Full Text] [Related]
5. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28.
Chew EY; Clemons TE; Agrón E; Domalpally A; Keenan TDL; Vitale S; Weber C; Smith DC; Christen W;
JAMA Ophthalmol; 2022 Jul; 140(7):692-698. PubMed ID: 35653117
[TBL] [Abstract][Full Text] [Related]
6. Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
; Bonds DE; Harrington M; Worrall BB; Bertoni AG; Eaton CB; Hsia J; Robinson J; Clemons TE; Fine LJ; Chew EY
JAMA Intern Med; 2014 May; 174(5):763-71. PubMed ID: 24638908
[TBL] [Abstract][Full Text] [Related]
7. Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial.
Chew EY; Clemons TE; Agrón E; Launer LJ; Grodstein F; Bernstein PS;
JAMA; 2015 Aug; 314(8):791-801. PubMed ID: 26305649
[TBL] [Abstract][Full Text] [Related]
8. No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18.
van Asten F; Chiu CY; Agrón E; Clemons TE; Ratnapriya R; Swaroop A; Klein ML; Fan R; Chew EY;
Ophthalmology; 2019 Nov; 126(11):1541-1548. PubMed ID: 31358387
[TBL] [Abstract][Full Text] [Related]
9. Effect of Dietary Supplementation With Lutein, Zeaxanthin, and ω-3 on Macular Pigment: A Randomized Clinical Trial.
Korobelnik JF; Rougier MB; Delyfer MN; Bron A; Merle BMJ; Savel H; Chêne G; Delcourt C; Creuzot-Garcher C
JAMA Ophthalmol; 2017 Nov; 135(11):1259-1266. PubMed ID: 28973076
[TBL] [Abstract][Full Text] [Related]
10. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1).
; Chew EY; Clemons T; SanGiovanni JP; Danis R; Domalpally A; McBee W; Sperduto R; Ferris FL
Ophthalmology; 2012 Nov; 119(11):2282-9. PubMed ID: 22840421
[TBL] [Abstract][Full Text] [Related]
11. Oral supplementation of lutein/zeaxanthin and omega-3 long chain polyunsaturated fatty acids in persons aged 60 years or older, with or without AMD.
Huang LL; Coleman HR; Kim J; de Monasterio F; Wong WT; Schleicher RL; Ferris FL; Chew EY
Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):3864-9. PubMed ID: 18450596
[TBL] [Abstract][Full Text] [Related]
12. Visual acuity after cataract surgery in patients with age-related macular degeneration: age-related eye disease study 2 report number 5.
; Huynh N; Nicholson BP; Agrón E; Clemons TE; Bressler SB; Rosenfeld PJ; Chew EY
Ophthalmology; 2014 Jun; 121(6):1229-36. PubMed ID: 24613825
[TBL] [Abstract][Full Text] [Related]
13. Age-related Eye Disease Study 2: perspectives, recommendations, and unanswered questions.
Aronow ME; Chew EY
Curr Opin Ophthalmol; 2014 May; 25(3):186-90. PubMed ID: 24614146
[TBL] [Abstract][Full Text] [Related]
14. Macular xanthophylls and ω-3 long-chain polyunsaturated fatty acids in age-related macular degeneration: a randomized trial.
Arnold C; Winter L; Fröhlich K; Jentsch S; Dawczynski J; Jahreis G; Böhm V
JAMA Ophthalmol; 2013 May; 131(5):564-72. PubMed ID: 23519529
[TBL] [Abstract][Full Text] [Related]
15. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.
Ma L; Yan SF; Huang YM; Lu XR; Qian F; Pang HL; Xu XR; Zou ZY; Dong PC; Xiao X; Wang X; Sun TT; Dou HL; Lin XM
Ophthalmology; 2012 Nov; 119(11):2290-7. PubMed ID: 22858124
[TBL] [Abstract][Full Text] [Related]
16. Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration.
Beatty S; Chakravarthy U; Nolan JM; Muldrew KA; Woodside JV; Denny F; Stevenson MR
Ophthalmology; 2013 Mar; 120(3):600-606. PubMed ID: 23218821
[TBL] [Abstract][Full Text] [Related]
17. The Association of Dietary Lutein plus Zeaxanthin and B Vitamins with Cataracts in the Age-Related Eye Disease Study: AREDS Report No. 37.
Glaser TS; Doss LE; Shih G; Nigam D; Sperduto RD; Ferris FL; Agrón E; Clemons TE; Chew EY;
Ophthalmology; 2015 Jul; 122(7):1471-9. PubMed ID: 25972257
[TBL] [Abstract][Full Text] [Related]
18. Macular pigment imaging in AREDS2 participants: an ancillary study of AREDS2 subjects enrolled at the Moran Eye Center.
Bernstein PS; Ahmed F; Liu A; Allman S; Sheng X; Sharifzadeh M; Ermakov I; Gellermann W
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6178-86. PubMed ID: 22879423
[TBL] [Abstract][Full Text] [Related]
19. Associations between age-related nuclear cataract and lutein and zeaxanthin in the diet and serum in the Carotenoids in the Age-Related Eye Disease Study, an Ancillary Study of the Women's Health Initiative.
Moeller SM; Voland R; Tinker L; Blodi BA; Klein ML; Gehrs KM; Johnson EJ; Snodderly DM; Wallace RB; Chappell RJ; Parekh N; Ritenbaugh C; Mares JA; ;
Arch Ophthalmol; 2008 Mar; 126(3):354-64. PubMed ID: 18332316
[TBL] [Abstract][Full Text] [Related]
20. The Association of Statin Use with Cataract Progression and Cataract Surgery: The AREDS2 Report Number 8.
; Al-Holou SN; Tucker WR; Agrón E; Clemons TE; Sperduto RD; Ferris FL; Chew EY
Ophthalmology; 2016 Apr; 123(4):916-7. PubMed ID: 26686966
[No Abstract] [Full Text] [Related]
[Next] [New Search]
